Risk factors for complications following sacral neuromodulation for faecal incontinence: Long-term follow-up.
faecal incontinence
long‐term complications sacral neuromodulation
risk factors
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
12 Jul 2024
12 Jul 2024
Historique:
revised:
19
06
2024
received:
13
03
2024
accepted:
22
06
2024
medline:
13
7
2024
pubmed:
13
7
2024
entrez:
13
7
2024
Statut:
aheadofprint
Résumé
Sacral neuromodulation (SNM) has become a standard surgical treatment for faecal incontinence (FI). Prior studies have reported various adverse events of SNM, including suboptimal therapeutic response, infection, pain, haematoma, and potential need for redo SNM. The aim of this study was to identify the risk factors associated with long-term complications of SNM. This retrospective cohort reviewed patients who underwent two-stage SNM for FI at our institution between 2011-2021. Preoperative baseline characteristics and follow-up were obtained from the medical record and/or by telephone interview. Management and outcome of each postoperative event were evaluated by univariate and multivariate regression analyses. A total of 291 patients (85.2% female) were included in this study. Postoperative complications were recorded in 219 (75.2%) patients and 154 (52.9%) patients required surgical intervention to treat complications. The most common postoperative event was loss of efficacy (46.4%). Other common adverse events were problems at the implant site (pain, infection, etc.) in 16.5% and pain during stimulation in 11.7%. Previous vaginal delivery (OR 2.74, p = 0.003) and anal surgery (OR = 2.46, p = 0.039) were independent predictors for complications. Previous colorectal (OR = 2.04, p = 0.026) and anal (OR = 1.98, p = 0.022) surgery and history of irritable bowel syndrome (IBS) (OR = 3.49, p = 0.003) were independent predictors for loss of efficacy. Postoperative adverse events are frequently recorded after SNM. Loss of efficacy is the most common. Previous colorectal or anal surgery, vaginal delivery, and IBS are independent risk factors for complications.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.
Références
Sharma A, Yuan L, Marshall RJ, Merrie AE, Bissett IP. Systematic review of the prevalence of faecal incontinence. Br J Surg. 2016;103:1589–1597. https://doi.org/10.1002/bjs.10298
Saldana Ruiz N, Kaiser AM. Fecal incontinence – challenges and solutions. World J Gastroenterol. 2017;23:11–24. https://doi.org/10.3748/wjg.v23.i1.11
Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet. 1995;346:1124–1127. https://doi.org/10.1016/s0140‐6736(95)91799‐3
Da Silva G, Mellgren A. Fecal incontinence: evaluation and treatment. In: Steele SR, Hull TL, Hyman N, Maykel JA, Read TE, Whitlow CB, editors. The ASCRS textbook of colon and rectal surgery. 4th ed. New York: Springer; 2022.
Meurette G, Siproudhis L, Leroi AM, Damon H, Urs Josef Keller D, Faucheron JL, et al. Sacral neuromodulation with the InterStim™ system for faecal incontinence: results from a prospective French multicentre observational study. Colorectal Dis. 2021;23(6):1463–1473. https://doi.org/10.1111/codi.15507
Force L, Dasilva G. Management of complications of sacral neuromodulation. Semin Colon Rectal Surg. 2017;28:173–176.
Altomare DF, Giuratrabocchetta S, Knowles CH, Muñoz Duyos A, Robert‐Yap J, Matzel KE. Long‐term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg. 2015;102:407–415. https://doi.org/10.1002/bjs.9740
Janssen PT, Kuiper SZ, Stassen LP, Bouvy ND, Breukink SO, Melenhorst J. Fecal incontinence treated by sacral neuromodulation: long‐term follow‐up of 325 patients. Surgery. 2017;161:1040–1048. https://doi.org/10.1016/j.surg.2016.10.038
Desprez C, Damon H, Meurette G, Mege D, Faucheron JL, Brochard C, et al. Ten‐year evaluation of a large retrospective cohort treated by sacral nerve modulation for fecal incontinence: results of a French multicenter study. Ann Surg. 2022;275:735–742. https://doi.org/10.1097/SLA.0000000000004251
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–835. https://doi.org/10.1097/EDE.0b013e3181577511
Matzel KE, Kamm MA, Stösser M, Baeten CGMI, Christiansen J, Madoff R, et al. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet. 2004;363:1270–1276. https://doi.org/10.1016/S0140‐6736(04)15999‐0 PMID: 15094271.
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993; Jan36(1):77–97. https://doi.org/10.1007/BF02050307. PMID: 8416784.
Kanda Y. Investigation of the freely available easy‐to‐use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458. https://doi.org/10.1038/bmt.2012.244
Maeda Y, Lundby L, Buntzen S, Laurberg S. Suboptimal outcome following sacral nerve stimulation for faecal incontinence. Br J Surg. 2011;98:140–147. https://doi.org/10.1002/bjs.7302
Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, Madoff RD, et al. Long‐term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234–245. https://doi.org/10.1097/DCR.0b013e318276b24c
Faucheron JL, Voirin D, Badic B. Sacral nerve stimulation for fecal incontinence: causes of surgical revision from a series of 87 consecutive patients operated on in a single institution. Dis Colon Rectum. 2010;53:1501–1507. https://doi.org/10.1007/DCR.0b013e3181f1cf14
Mizrahi I, Chadi SA, Haim N, Sands DR, Gurland B, Zutshi M, et al. Sacral neuromodulation for the treatment of faecal incontinence following proctectomy. Colorectal DisColorectal Dis. 2017;19(5):O145–O152. https://doi.org/10.1111/codi.13570
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–958. https://doi.org/10.1001/jama.2015.0954
Kirss J Jr, Pinta T, Varpe P, Rautio T, Kairaluoma M, Hyöty M, et al. Outcomes of treatment of faecal incontinence with sacral nerve stimulation ‐ a Finnish multicentre study. Color Dis. 2019;21:59–65. https://doi.org/10.1111/codi.14406
Chan MKY, Tjandra JJ. Sacral nerve stimulation for fecal incontinence: external anal sphincter defect vs. intact anal sphincter. Dis Colon Rectum. 2008;51:1015–1025.
Huang Y, Koh CE. Sacral nerve stimulation for bowel dysfunction following low anterior resection: a systematic review and meta‐analysis. Color Dis. 2019;21:1240–1248. https://doi.org/10.1111/codi.14690
Ram E, Meyer R, Carter D, Gutman M, Rosin D, Horesh N. The efficacy of sacral neuromodulation in the treatment of low anterior resection syndrome: a systematic review and meta‐analysis. Tech Coloproctol. 2020;24:803–815. https://doi.org/10.1007/s10151‐020‐02231‐8
Duelund‐Jakobsen J, Buntzen S, Laurberg S, Lundby L. Improved longevity and efficacy of sacral nerve stimulation by simple adjustments at follow‐up. Color Dis. 2020;22:310–318. https://doi.org/10.1111/codi.14874